id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-1306-0005,FDA,FDA-2026-P-1306,Response Letter,Other,Letter(s),2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T20:50:07Z,,0,0,09000064b92c5f8f
FDA-2026-P-1306-0004,FDA,FDA-2026-P-1306,"Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T17:34:01Z,2026-08939,0,0,09000064b92c65a4
FDA-2026-P-1306-0001,FDA,FDA-2026-P-1306,"Citizen Petition from Lachman Consultant Services, Inc.",Other,Citizen Petition,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,,2026-05-06T18:25:24Z,,0,0,09000064b9193898
FDA-2026-P-1306-0003,FDA,FDA-2026-P-1306,Attachment 1,Supporting & Related Material,Background Material,2026-02-05T05:00:00Z,2026,2,,,2026-02-06T00:30:22Z,,0,0,09000064b91938a0
FDA-2026-P-1306-0002,FDA,FDA-2026-P-1306,"Acknowledgement Letter from FDA DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,,2026-02-06T00:30:15Z,,0,0,09000064b919389e